Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview
2016-01-01 Salvi, S.; Conteduca, V.; Gurioli, G.; Calistri, D.; Casadio, V.; De Giorgi, U.
The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: An unresolved controversy
2013-01-01 Conteduca, V.; Di Lorenzo, G.; Tartarone, A.; Aieta, M.
Immunotherapy for prostate cancer: Where we are headed
2017-01-01 Schepisi, G.; Farolfi, A.; Conteduca, V.; Martignano, F.; De Lisi, D.; Ravaglia, G.; Rossi, L.; Menna, C.; Bellia, S. R.; Barone, D.; Gunelli, R.; De Giorgi, U.
Axitinib after Sunitinib in metastatic renal cancer: Preliminary results from Italian "Real-World" SAX Study
2016-01-01 D'Aniello, C.; Vitale, M. G.; Farnesi, A.; Calvetti, L.; Laterza, M. M.; Cavaliere, C.; Pepa, C. D.; Conteduca, V.; Crispo, A.; De Vita, F.; Grillone, F.; Ricevuto, E.; De Tursi, M.; De Vivo, R.; Di Napoli, M.; Cecere, S. C.; Iovane, G.; Amore, A.; Piscitelli, R.; Quarto, G.; Pisconti, S.; Ciliberto, G.; Maiolino, P.; Muto, P.; Perdona, S.; Berretta, M.; Naglieri, E.; Galli, L.; Carteni, G.; Giorgi, U. D.; Pignata, S.; Facchini, G.; Rossetti, S.
Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone
2017-01-01 Conteduca, V.; Caffo, O.; Lolli, C.; Aieta, M.; Scarpi, E.; Bianchi, E.; Maines, F.; Schepisi, G.; Salvi, S.; Massari, F.; Carrozza, F.; Veccia, A.; Chiuri, V. E.; Campadelli, E.; Facchini, G.; De Giorgi, U.
Endoscopic ultrasound fine-needle biopsy versus fine-needle aspiration for tissue sampling of abdominal lymph nodes: A propensity score matched multicenter comparative study
2021-01-01 Facciorusso, A.; Crino, S. F.; Muscatiello, N.; Gkolfakis, P.; Samanta, J.; Londono Castillo, J.; Cotsoglou, C.; Ramai, D.
Barrett's esophagus and esophageal cancer: An overview
2012-01-01 Conteduca, V.; Sansonno, D.; Ingravallo, G.; Marangi, S.; Russi, S.; Lauletta, G.; Dammacco, F.
Comparative efficacy of different methods for difficult biliary cannulation in ERCP: a systematic review and network meta-analysis
2021-01-01 Facciorusso, Antonio; Ramai, Daryl; Gkolfakis, Paraskevas; Khan, Shahab R; Papanikolaou, Ioannis S; Triantafyllou, Konstantinos; Tringali, Alberto; Chandan, Saurabh; Mohan, Babu P; Adler, Douglas G
Molecular mechanisms of resistance in testicular germ cell tumors - Clinical implications
2018-01-01 Kalavska, K.; Conteduca, V.; De Giorgi, U.; Mego, M.
30-Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID-19 pandemic – The GENEVA study
2021-01-01 Rishi, Singhal; Tom, Wiggins; Jonathan, Super; Aayed, Alqahtani; Nadler, Evan P.; Christian, Ludwig; Abd, Tahrani; Kamal, Mahawar; Tartaglia, Nicola; Ambrosi, Antonio; Pavone, Giovanna
Molecular mechanisms of resistance in testicular germ cell tumors - Clinical implications
2018-01-01 Kalavska, K.; Conteduca, V.; De Giorgi, U.; Mego, M.
Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy?
2018-01-01 De Lisi, D; De Giorgi, U; Lolli, C; Schepisi, G; Conteduca, V; Menna, C; Tonini, G; Santini, D; Farolfi, A.
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study
2021-01-01 COVIDSurg Collaborative and GlobalSurg, Collaborative; Tartaglia, Nicola; Cotoia, Antonella
Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program
2018-01-01 Maines, F; De Giorgi, U; Procopio, G; Facchini, G; Fratino, L; Sabbatini, R; Gasparro, D; Basso, U; Mosillo, C; Campadelli, E; Massari, F; Sava, T; Sirotova, S; Messina, C; Scagliarini, S; Conteduca, V; Verzoni, E; Rossetti, S; Veccia, A; Kinspergher, S; Caffo, O.
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer
2018-01-01 Conteduca, V; Scarpi, E; Salvi, S; Casadio, V; Lolli, C; Gurioli, G; Schepisi, G; Wetterskog, D; Farolfi, A; Menna, C; De Lisi, D; Burgio, Sl; Beltran, H; Attard, G; De Giorgi, U.
Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test
2019-01-01 González-Billalabeitia, E; Conteduca, V; Wetterskog, D; Jayaram, A; Attard, G.
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer
2018-01-01 Conteduca, V; Gurioli, G; Rossi, L; Scarpi, E; Lolli, C; Schepisi, G; Farolfi, A; De Lisi, D; Gallà, V; Burgio, Sl; Menna, C; Amadori, A; Losi, L; Amadori, D; Costi, Mp; De Giorgi, U.
BRCA2-Associated Prostate Cancer in a Patient With Spinal and Bulbar Muscular Atrophy
2018-01-01 Conteduca, V; Sigouros, M; Sboner, A; Pritchard, Cc; Beltran, H.
New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer.
2021-01-01 Conteduca, V; Mosca, A; Brighi, N; de Giorgi, U; Rescigno, P.
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma.
2021-01-01 Conteduca, V; Scarpi, E; Farolfi, A; Brighi, N; Rossi, L; Gurioli, G; Lolli, C; Schepisi, G; Bleve, S; Gianni, C; Virga, A; Altavilla, A; Burgio, Sl; Menna, C; De Giorgi, U.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview | 1-gen-2016 | Salvi, S.; Conteduca, V.; Gurioli, G.; Calistri, D.; Casadio, V.; De Giorgi, U. | |
| The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: An unresolved controversy | 1-gen-2013 | Conteduca, V.; Di Lorenzo, G.; Tartarone, A.; Aieta, M. | |
| Immunotherapy for prostate cancer: Where we are headed | 1-gen-2017 | Schepisi, G.; Farolfi, A.; Conteduca, V.; Martignano, F.; De Lisi, D.; Ravaglia, G.; Rossi, L.; Menna, C.; Bellia, S. R.; Barone, D.; Gunelli, R.; De Giorgi, U. | |
| Axitinib after Sunitinib in metastatic renal cancer: Preliminary results from Italian "Real-World" SAX Study | 1-gen-2016 | D'Aniello, C.; Vitale, M. G.; Farnesi, A.; Calvetti, L.; Laterza, M. M.; Cavaliere, C.; Pepa, C. D.; Conteduca, V.; Crispo, A.; De Vita, F.; Grillone, F.; Ricevuto, E.; De Tursi, M.; De Vivo, R.; Di Napoli, M.; Cecere, S. C.; Iovane, G.; Amore, A.; Piscitelli, R.; Quarto, G.; Pisconti, S.; Ciliberto, G.; Maiolino, P.; Muto, P.; Perdona, S.; Berretta, M.; Naglieri, E.; Galli, L.; Carteni, G.; Giorgi, U. D.; Pignata, S.; Facchini, G.; Rossetti, S. | |
| Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone | 1-gen-2017 | Conteduca, V.; Caffo, O.; Lolli, C.; Aieta, M.; Scarpi, E.; Bianchi, E.; Maines, F.; Schepisi, G.; Salvi, S.; Massari, F.; Carrozza, F.; Veccia, A.; Chiuri, V. E.; Campadelli, E.; Facchini, G.; De Giorgi, U. | |
| Endoscopic ultrasound fine-needle biopsy versus fine-needle aspiration for tissue sampling of abdominal lymph nodes: A propensity score matched multicenter comparative study | 1-gen-2021 | Facciorusso, A.; Crino, S. F.; Muscatiello, N.; Gkolfakis, P.; Samanta, J.; Londono Castillo, J.; Cotsoglou, C.; Ramai, D. | |
| Barrett's esophagus and esophageal cancer: An overview | 1-gen-2012 | Conteduca, V.; Sansonno, D.; Ingravallo, G.; Marangi, S.; Russi, S.; Lauletta, G.; Dammacco, F. | |
| Comparative efficacy of different methods for difficult biliary cannulation in ERCP: a systematic review and network meta-analysis | 1-gen-2021 | Facciorusso, Antonio; Ramai, Daryl; Gkolfakis, Paraskevas; Khan, Shahab R; Papanikolaou, Ioannis S; Triantafyllou, Konstantinos; Tringali, Alberto; Chandan, Saurabh; Mohan, Babu P; Adler, Douglas G | |
| Molecular mechanisms of resistance in testicular germ cell tumors - Clinical implications | 1-gen-2018 | Kalavska, K.; Conteduca, V.; De Giorgi, U.; Mego, M. | |
| 30-Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID-19 pandemic – The GENEVA study | 1-gen-2021 | Rishi, Singhal; Tom, Wiggins; Jonathan, Super; Aayed, Alqahtani; Nadler, Evan P.; Christian, Ludwig; Abd, Tahrani; Kamal, Mahawar; Tartaglia, Nicola; Ambrosi, Antonio; Pavone, Giovanna | |
| Molecular mechanisms of resistance in testicular germ cell tumors - Clinical implications | 1-gen-2018 | Kalavska, K.; Conteduca, V.; De Giorgi, U.; Mego, M. | |
| Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy? | 1-gen-2018 | De Lisi, D; De Giorgi, U; Lolli, C; Schepisi, G; Conteduca, V; Menna, C; Tonini, G; Santini, D; Farolfi, A. | |
| SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study | 1-gen-2021 | COVIDSurg Collaborative and GlobalSurg, Collaborative; Tartaglia, Nicola; Cotoia, Antonella | |
| Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program | 1-gen-2018 | Maines, F; De Giorgi, U; Procopio, G; Facchini, G; Fratino, L; Sabbatini, R; Gasparro, D; Basso, U; Mosillo, C; Campadelli, E; Massari, F; Sava, T; Sirotova, S; Messina, C; Scagliarini, S; Conteduca, V; Verzoni, E; Rossetti, S; Veccia, A; Kinspergher, S; Caffo, O. | |
| Plasma androgen receptor and serum chromogranin A in advanced prostate cancer | 1-gen-2018 | Conteduca, V; Scarpi, E; Salvi, S; Casadio, V; Lolli, C; Gurioli, G; Schepisi, G; Wetterskog, D; Farolfi, A; Menna, C; De Lisi, D; Burgio, Sl; Beltran, H; Attard, G; De Giorgi, U. | |
| Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test | 1-gen-2019 | González-Billalabeitia, E; Conteduca, V; Wetterskog, D; Jayaram, A; Attard, G. | |
| Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer | 1-gen-2018 | Conteduca, V; Gurioli, G; Rossi, L; Scarpi, E; Lolli, C; Schepisi, G; Farolfi, A; De Lisi, D; Gallà, V; Burgio, Sl; Menna, C; Amadori, A; Losi, L; Amadori, D; Costi, Mp; De Giorgi, U. | |
| BRCA2-Associated Prostate Cancer in a Patient With Spinal and Bulbar Muscular Atrophy | 1-gen-2018 | Conteduca, V; Sigouros, M; Sboner, A; Pritchard, Cc; Beltran, H. | |
| New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer. | 1-gen-2021 | Conteduca, V; Mosca, A; Brighi, N; de Giorgi, U; Rescigno, P. | |
| Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma. | 1-gen-2021 | Conteduca, V; Scarpi, E; Farolfi, A; Brighi, N; Rossi, L; Gurioli, G; Lolli, C; Schepisi, G; Bleve, S; Gianni, C; Virga, A; Altavilla, A; Burgio, Sl; Menna, C; De Giorgi, U. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista31120
- 4 Contributo in Atti di Convegno ...3
Data di pubblicazione
- In corso di stampa39
- 2020 - 20269083
- 2010 - 201911275
- 2000 - 20096752
- 1990 - 19992845
- 1980 - 1989901
- 1970 - 1979224
- 1967 - 19693
Editore
- Lippincott, Williams & Wilkins:53...116
- Giuffre Editore Spa:via Busto Ars...112
- Elsevier Science Limited:Oxford F...106
- Elsevier BV:PO Box 211, 1000 AE A...103
- Blackwell Munksgaard:PO Box 2148,...93
- Blackwell Science Limited:PO Box ...91
- Edizioni Minerva Medica:Corso Bra...74
- Chiriotti Editori Spa:PO Box 66, ...70
- W B Saunders Company:Fulfillment ...69
- Springer Verlag Germany:Tiergarte...65
Rivista
- PHYSICAL REVIEW LETTERS267
- PHYSICS LETTERS. SECTION B182
- JOURNAL OF CLINICAL MEDICINE169
- INTERNATIONAL JOURNAL OF MOLECULA...166
- PHYSICAL REVIEW D, PARTICLES, FIE...161
- ACTA HORTICULTURAE159
- INTERNATIONAL JOURNAL OF CARDIOLOGY145
- PLOS ONE138
- JOURNAL OF BIOLOGICAL REGULATORS ...127
- LA RADIOLOGIA MEDICA126
Keyword
- Humans1202
- Male648
- Female591
- Middle Aged399
- Adult327
- Aged325
- Italy285
- COVID-19246
- Animals221
- Medicine (all)160
Lingua
- eng18061
- ita5528
- spa132
- fre99
- ger44
- lat30
- grc27
- enm19
- por18
- pol5
Accesso al fulltext
- no fulltext30652
- open363
- restricted77
- reserved29
- partially open1